Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-13-001593
Filing Date
2013-01-31
Accepted
2013-01-31 20:32:38
Documents
1
Period of Report
2013-01-30

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 3788
  Complete submission text file 0001179110-13-001593.txt   4978
Mailing Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
RIGEL PHARMACEUTICALS INC (Issuer) CIK: 0001034842 (see all company filings)

EIN.: 943248524 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address
VANCE DOLLY (Reporting) CIK: 0001237676 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-29889 | Film No.: 13564433